Pernasally absorbable insulin preparations
US6911213B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 26, 2001 |
| Grant date | Jun 28, 2005 |
| Priority date | — |
| Expiry date | Apr 26, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An insulin formulation with porous, spherical calcium carbonate composed of trabeculate or needle-shaped crystals, or an aggregation of the parallel intergrowth of these forms, as its carrier, will be presented. This formulation is beneficial for the treatment of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.